Sanders to pharma firm: Why are you charging $375,000 for life-saving drug?
Sen. Bernie Sanders, I-Vt., has sent a letter to Florida-based Catalyst Pharmaceuticals Inc. demanding to know why it is charging $375,000 for a drug that treats a rare disease. In the letter, released Monday, Sanders asked Catalyst CEO Patrick McEnany how many patients “will suffer or die” due to the...